Biotech News

Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

Seer, Inc (SEER)Seer, Inc2026-02-26 21:06 ESTCompany update

REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors unanimously adopted a tax benefit preservation plan (“NOL Plan”) designed to help preserve and

Seer, Inc

Deep Proteomics Company Seer develops tools for large-scale, unbiased analysis of the proteome across research, translational medicine, and drug development. Proteograph Product Suite The Proteograph platform combines engineered nanoparticles, automated sample processing, consumables, and analytical software to capture proteins across a...

Recent company news

SEERSeer, Inc2026-08-11 20:05 EST

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.

SEERSeer, Inc2026-07-28 21:40 EST

Seer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting

Stock data

Close: 2.03 USD
Market cap: 102.82M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States

Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

Related news

Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference